Key result
Ultrasonic dopplerography detects decreased microvascular blood flow in diabetes and stages cardiac autonomic neuropathy.
Why the study?
Diabetic autonomic neuropathy underlies early morbidity and mortality in diabetes, driving the need for new diagnostic methods.
Does high-frequency ultrasonic dopplerography accurately diagnose and stage cardiac autonomic neuropathy in patients with type 2 diabetes?
Observational (n=36)
No
Does high-frequency ultrasonic dopplerography accurately diagnose and stage cardiac autonomic neuropathy in patients with type 2 diabetes?
High-frequency ultrasonic dopplerography, paired with functional tests, offers a non-invasive and effective method for the early diagnosis and staging of cardiac autonomic neuropathy in diabetic patients.
Answers are grounded in this paper and cite their sources.
May aid non-invasive staging of diabetic cardiac autonomic neuropathy; leaves open prospective validation before clinical use.
Introduction. Diabetic neuropathy is the most wide-spread complication of diabetes mellitus and neuropathy is steadily progressing even with compensation of the underlying disease. The search of the new methods of treatment and diagnosis of neuropathy is required. Diabetic autonomic neuropathy lies in the base of early morbidity and mortality of diabetic patients. We estimated the potential of High-frequency Ultrasonic Dopplerography for diagnosis of autonomic neuropathy. Material and methods. 26 diabetic patients with sensorimotor neuropathy were examined. Microvascular blood flow of finger skin was assessed at rest as well as in functional tests: with cold impact and occlusion (cuff). Cardiac autonomic neuropathy was assessed using several cardiovascular autonomic reflex tests as a gold standard of diagnosis. Diagnostic values of microvascular blood flow test in detecting of cardiac autonomic neuropathy staging were evaluated in comparing with traditional modalities. Results. Cardiac autonomic neuropathy was found for all patients and definite/confirmed staging in 61.5 % cases. Initial parameters of microvascular blood flow velocity were significantly decreased in all patients in comparing with control (Vam= = (1.9±0.22); (1.7±0.51) and (6.7±0.51) sm/s in patients with early cardiac autonomic neuropathy, definite/confirmed staging and control subjects respectively, p<0.05). Microvascular blood flow functional testes had great informational content for diagnosis of autonomic neuropathy (sensitivity – 100 and 58 %, specify – 50 and 80 % respectively). The algorithm of diabetic patients examination was offered for early diagnosis of autonomic neuropathy staging. Conclusions. High-frequency Ultrasonic Dopplerography allowed to separate of cardiac autonomic neuropathy stages. This study is necessary to continue for revealing of all method possibilities.
No takes yet. Share an insight, caveat, or question.
Зеленина et al. (2019) conducted an observational in Type 2 diabetes mellitus with sensorimotor neuropathy and cardiac autonomic neuropathy (n=36). High-frequency ultrasonic dopplerography vs. Healthy controls was evaluated on Initial parameters of microvascular blood flow velocity (Vam) (p=<0.05). High-frequency ultrasonic dopplerography revealed significantly decreased microvascular blood flow velocity in diabetic patients compared to controls and successfully separated cardiac autonomic neuropathy stages.
Synapse has enriched 10 related papers. Consider them for comparative context: